vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
LINKBANCORP, Inc. is the larger business by last-quarter revenue ($46.0M vs $44.9M, roughly 1.0× AbCellera Biologics Inc.). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -19.9%, a 26.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 6.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
ABCL vs LNKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $46.0M |
| Net Profit | $-8.9M | $2.9M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 8.5% |
| Net Margin | -19.9% | 6.4% |
| Revenue YoY | 788.4% | 7.3% |
| Net Profit YoY | 73.9% | -61.2% |
| EPS (diluted) | $-0.03 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $46.0M | ||
| Q3 25 | $9.0M | $44.8M | ||
| Q2 25 | $17.1M | $42.3M | ||
| Q1 25 | $4.2M | $53.4M | ||
| Q4 24 | $5.0M | $42.9M | ||
| Q3 24 | $6.5M | $42.9M | ||
| Q2 24 | $7.3M | $41.3M | ||
| Q1 24 | $10.0M | $40.5M |
| Q4 25 | $-8.9M | $2.9M | ||
| Q3 25 | $-57.1M | $7.8M | ||
| Q2 25 | $-34.7M | $7.4M | ||
| Q1 25 | $-45.6M | $15.3M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-51.1M | $7.1M | ||
| Q2 24 | $-36.9M | $5.8M | ||
| Q1 24 | $-40.6M | $5.7M |
| Q4 25 | -63.7% | 8.5% | ||
| Q3 25 | -851.8% | 22.3% | ||
| Q2 25 | -290.2% | 22.4% | ||
| Q1 25 | -1479.6% | 36.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -1439.4% | 21.3% | ||
| Q2 24 | -1276.2% | 18.0% | ||
| Q1 24 | -551.5% | 18.1% |
| Q4 25 | -19.9% | 6.4% | ||
| Q3 25 | -637.8% | 17.5% | ||
| Q2 25 | -203.3% | 17.5% | ||
| Q1 25 | -1077.2% | 28.7% | ||
| Q4 24 | — | 17.7% | ||
| Q3 24 | -785.4% | 16.5% | ||
| Q2 24 | -504.3% | 14.1% | ||
| Q1 24 | -408.0% | 14.1% |
| Q4 25 | $-0.03 | $0.08 | ||
| Q3 25 | $-0.19 | $0.21 | ||
| Q2 25 | $-0.12 | $0.20 | ||
| Q1 25 | $-0.15 | $0.41 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-0.17 | $0.19 | ||
| Q2 24 | $-0.13 | $0.16 | ||
| Q1 24 | $-0.14 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $52.3M |
| Total DebtLower is stronger | — | $177.3M |
| Stockholders' EquityBook value | $966.9M | $306.4M |
| Total Assets | $1.4B | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $52.3M | ||
| Q3 25 | $83.2M | $194.2M | ||
| Q2 25 | $92.4M | $155.1M | ||
| Q1 25 | $159.3M | $220.2M | ||
| Q4 24 | $156.3M | $166.1M | ||
| Q3 24 | $126.6M | $191.2M | ||
| Q2 24 | $148.3M | $181.7M | ||
| Q1 24 | $123.6M | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | — | $102.3M | ||
| Q2 25 | — | $102.3M | ||
| Q1 25 | — | $102.7M | ||
| Q4 24 | — | $112.5M | ||
| Q3 24 | — | $102.4M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | — | $102.2M |
| Q4 25 | $966.9M | $306.4M | ||
| Q3 25 | $964.0M | $305.5M | ||
| Q2 25 | $1.0B | $298.0M | ||
| Q1 25 | $1.0B | $294.1M | ||
| Q4 24 | $1.1B | $280.2M | ||
| Q3 24 | $1.1B | $277.4M | ||
| Q2 24 | $1.1B | $271.4M | ||
| Q1 24 | $1.1B | $268.2M |
| Q4 25 | $1.4B | $3.1B | ||
| Q3 25 | $1.4B | $3.1B | ||
| Q2 25 | $1.4B | $2.9B | ||
| Q1 25 | $1.3B | $2.9B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.4B | $2.9B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.5B | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $25.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $23.8M |
| FCF MarginFCF / Revenue | -99.4% | 51.7% |
| Capex IntensityCapex / Revenue | 21.9% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $25.3M | ||
| Q3 25 | $-52.6M | $23.6M | ||
| Q2 25 | $-32.4M | $6.3M | ||
| Q1 25 | $-11.6M | $2.6M | ||
| Q4 24 | $-108.6M | $25.4M | ||
| Q3 24 | $-28.9M | $14.0M | ||
| Q2 24 | $-30.0M | $6.4M | ||
| Q1 24 | $-41.7M | $-771.0K |
| Q4 25 | $-44.6M | $23.8M | ||
| Q3 25 | $-61.5M | $23.2M | ||
| Q2 25 | $-45.8M | $6.1M | ||
| Q1 25 | $-22.2M | $2.2M | ||
| Q4 24 | $-187.0M | $22.6M | ||
| Q3 24 | $-47.4M | $13.1M | ||
| Q2 24 | $-50.1M | $6.3M | ||
| Q1 24 | $-65.8M | $-1.2M |
| Q4 25 | -99.4% | 51.7% | ||
| Q3 25 | -687.0% | 51.8% | ||
| Q2 25 | -267.9% | 14.5% | ||
| Q1 25 | -524.0% | 4.2% | ||
| Q4 24 | -3702.8% | 52.6% | ||
| Q3 24 | -728.4% | 30.5% | ||
| Q2 24 | -683.8% | 15.3% | ||
| Q1 24 | -661.5% | -3.0% |
| Q4 25 | 21.9% | 3.2% | ||
| Q3 25 | 99.7% | 0.8% | ||
| Q2 25 | 78.2% | 0.4% | ||
| Q1 25 | 251.1% | 0.7% | ||
| Q4 24 | 1552.7% | 6.7% | ||
| Q3 24 | 284.6% | 2.1% | ||
| Q2 24 | 274.6% | 0.1% | ||
| Q1 24 | 242.5% | 1.1% |
| Q4 25 | — | 8.59× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 3.35× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
